Health activists demand government action to reduce the cost of SMA medicines, citing constitutional obligations and ...

Muscle atrophy, characterized by the loss of muscle mass and function, is a hallmark of sarcopenia and cachexia and is frequently associated with aging, malignant tumors, chronic heart failure, and ...

The health activists argue that the government is empowered with effective law and policy tools and therefore should ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

The supplement is designed to enhance muscle function and strength for dogs that are aging, active or undergoing muscle ...

An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines Agency (EMA) considerate it as an alternative than the current lower ...

Biogen’s applications for the higher dose regimen of spinal muscular atrophy (SMA) drug Spinraza are now under review in the US and Europe.

Without this protein, motor neurons deteriorate, leading to muscle weakness, impaired movement, and eventually respiratory failure,' say a Calcutta-based neurologist ...

Biogen said the U.S. Food and Drug Administration has accepted its supplemental new-drug application, while the European Medicines Agency has validated its application, which confirms that the ...